UniSA Professor Richard D'Andrea and Associate Professor Lisa Ebert in the new lab.A new tissue culture facility has opened at UniSA today, helping to ...
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...
Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New ...
Headquartered in Wexford, PA, COEPTIS is dedicated to advancing its mission within the regulatory framework set forth by the FDA, ensuring that all activities align with the highest standards of ...
T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) ...
With MarketLeverage’s extensive industry expertise and NexGenAI Affiliates Network’s innovative AI-powered platform, this collaboration will empower affiliates, brands, and marketers with advanced ...
What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
The new treatment option is known as tumor-infiltrating lymphocyte (TIL) therapy. It’s designed for patients with metastatic ...
Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.
News Medical on MSN23h
Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarringA discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback